Skip to main content
Premium Trial:

Request an Annual Quote

Illumina CEO Sold $3.3M Worth of Company Stock Since Start of 2006

NEW YORK (GenomeWeb News) - Illumina CEO Jay Flatley sold 2,500 shares of the company's stock at $35.04 apiece for total proceeds of $87,600 on Aug. 10, according to documents filed with the Securities and Exchange Commission on Monday.
He sold 14,000 shares this month before last week's transaction for total proceeds of $515,466. He currently owns 647,998 shares of Ilumina stock.
Shares in Illumina were down 6.8 percent, or $2.34, to $32.09 in mid-afternoon trading today. 
Flatley has sold 119,500 shares since the beginning of the year, pocketing almost $3.3 million in proceeds.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.